# Epsilogen Ltd. funding: rounds and investors

> Epsilogen Ltd. has raised $41M across 1 round since 2022. Investors include Novartis Venture Fund, Epidarex Capital and Schroders Capital.

Source: https://millionrounds.com/company/epsilogen-ltd (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Epsilogen Ltd.*

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$41M** raised across 1 round since 2022, from 17 sources

- **Latest round:** Series B, $41M Mar 2022
- **Led by:** Novartis Venture Fund
- **Investors:** 7 (1 led)

See who backed them

## The rounds

- **Mar 2022** Series B **$41M** [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) Lead [Epidarex Capital](https://millionrounds.com/fund/epidarex-capital) [Schroders Capital](https://millionrounds.com/fund/schroders-capital) [3B Future Health Fund I & II](https://millionrounds.com/fund/3b-future-health-fund-i-and-ii) [British Patient Capital](https://millionrounds.com/fund/british-patient-capital) [ALSA Ventures](https://millionrounds.com/fund/alsa-ventures) [Caribou Property](https://millionrounds.com/fund/caribou-property) Reported by UCL Technology Fund and 16 others

## Funding filed with regulators

Epsilogen Ltd. filed 6 raises, $117M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Aug 2025 **$14M** UK share allotment
- Mar 2025 **$37M** UK share allotment
- Sept 2024 **$1.4M** UK share allotment
- Aug 2024 **$35M** UK share allotment
- Dec 2023 **$6.4M** UK share allotment
- Feb 2022 **$23M** UK share allotment

## Founders and team

From Epsilogen Ltd.'s own website: 10 on the team.

- **Cristina Oliva** Chief Medical Officer
- **Elizabeth Hardaker** Chief Translational Science Officer
- **Kevin FitzGerald** Chief Scientific Officer
- **Nick Robbins-Cherry** Chief Financial Officer
- **Leanne Partington** VP of Product Development
- **Alek Safarian** Board Member
- **Marianne Bjørdal** Board Member
- **Marianne Uteng** Board Member
- **Pete Finan** Non-Executive Chairman
- **Sonia Gulati** Board Member

Advisers *Josep Tabernero Clinical Advisor*

## Everyone who backed them

[Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) Corporate VC **1** round, led 1

[Epidarex Capital](https://millionrounds.com/fund/epidarex-capital) VC firm **1** round

[Schroders Capital](https://millionrounds.com/fund/schroders-capital) Hedge fund **1** round

[3B Future Health Fund I & II](https://millionrounds.com/fund/3b-future-health-fund-i-and-ii) VC firm **1** round

[British Patient Capital](https://millionrounds.com/fund/british-patient-capital) Fund of funds **1** round

[ALSA Ventures](https://millionrounds.com/fund/alsa-ventures) VC firm **1** round

[Caribou Property](https://millionrounds.com/fund/caribou-property) Growth equity **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=epsilogen-ltd).

## Quick answers about Epsilogen Ltd.

### Who invested in Epsilogen Ltd.?

Epsilogen Ltd.'s investors include Novartis Venture Fund, Epidarex Capital, Schroders Capital, 3B Future Health Fund I & II and British Patient Capital, and 2 more on record. Novartis Venture Fund led its latest round.

### How much has Epsilogen Ltd. raised?

Epsilogen Ltd. has raised $41M across 1 round since 2022.

### When did Epsilogen Ltd. last raise?

Epsilogen Ltd.'s most recent round was a Series B of $41M in Mar 2022, led by Novartis Venture Fund.

### What was Epsilogen Ltd.'s biggest round?

Its most recent round, $41M in Mar 2022, is also its largest on record.

### Who backed Epsilogen Ltd. first?

Epsilogen Ltd.'s first round on record, in Mar 2022, was backed by Novartis Venture Fund, Epidarex Capital and Schroders Capital and 4 others.

### What stage is Epsilogen Ltd. at?

Epsilogen Ltd.'s latest named round is a Series B, in Mar 2022.

### Where is Epsilogen Ltd. based?

Epsilogen Ltd. is based in the United Kingdom.

### Who led Epsilogen Ltd.'s rounds?

Novartis Venture Fund led the Series B in 2022.

## Companies like Epsilogen Ltd.

In the same sector, and raised in the last eighteen months.

[**Coherence Neuro** $55M · Oct 2026](https://millionrounds.com/company/coherence-neuro)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**XRlabs** $8.4M · Oct 2026](https://millionrounds.com/company/xrlabs)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**MintNeuro** $26M · Oct 2026](https://millionrounds.com/company/mintneuro)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app